DENGUE CASE INVESTIGATION REPORT CDC Dengue Branch and Puerto Rico Department of Health 1324 Calle Cañada, San Juan, P. R. 00920-3860 Tel. (787) 706-2399,

Slides:



Advertisements
Similar presentations
DENGUE HEMORRHAGIC FEVER
Advertisements

HISTORY TAKING OF FEVER
Flight Surgeon RSV Day I n t e g r i t y - S e r v i c e - E x c e l l e n c e ANGRC Joint Base Andrews UNCLASSIFIED.
Ebola Virus Disease. EVD Description Hemorrhagic fever with case fatality rate up to 90% Endemic areas: Central and West Africa Wildlife reservoir: bats.
III. Clinical Manifestations of Dengue and Dengue Hemorrhagic Fever CENTERS FOR DISEASE CONTROL AND PREVENTION.
Mosquito-borne Arbovirus Surveillance in West Virginia Rachel Radcliffe, DVM, MPH CDC Career Epidemiology Field Officer Division of Infectious Disease.
Management of Dengue Fever Dr David Tran 16/09/09.
Re-emergence of locally acquired Dengue Fever in Palm Beach County, Florida Robert Parkes, MD; Sandra Warren, MPH, JoEllen Alvarez, RN, MPH, Barbara.
By Abhinay Sharma Bhugoo.  1648: First recognized outbreak of YF occurring in the New World. YF virus most likely introduced by slave- trading vessels.
Testing algorithms used at Bureau of Labs Michigan Department of Community Health Information on testing algorithms for processing and reporting serological.
TM Centers for Disease Control and Prevention National Center on Birth Defects and Developmental Disabilities Centers for Disease Control and Prevention.
Dengue Virus Causes dengue and dengue hemorrhagic fever
EBOLA Virus Disease August 22, What is Ebola Virus Disease (EVD)? Ebola virus disease (also known as Ebola hemorrhagic fever) is a severe, often-fatal.
OnSite Rubella IgG/IgM Rapid Test Novel Unique & Only Semi-Quantitative 4-Line Rapid Test.
Laboratory Investigation
DR. M MOHAMMED ARIF. ASSOCIATE PROFESSOR. CONSULTANT VIROLOGIST. HEAD OF THE VIROLOGY UNIT. Arboviruses.
Andrea Montelibano Isabelle Escobillo. The Virus Flavivirus Single strand RNA 4 serotypes – DENV-1 – DENV-2 – DENV-3 – DENV-4 Infection with one serotype.
Facility ID: Vaccination #: Healthcare Worker Demographics *HCW ID#: HCW Name, Last:First:Middle: *Gender:  F  M *Date of Birth: *Work Location: *Occupation:
Rash Decisions: The Colorado Experience with “Maybe Measles” Emily Spence Davizon, Colorado Department of Public Health and Environment.
Dengue ..
Tropical Fevers Case 1: 27 year old woman comes to a local health unit with history of a gradual onset of fever and headache and loss of appetite over.
Submitted by: Susan Henry Keith Noble
Public Health Perspective on SARS Diagnostics Stephen M. Ostroff Deputy Director National Center for Infectious Diseases, CDC.
Facility ID:Event #: *Patient ID:Social Security #: Secondary ID: Patient Name, Last: First: Middle: *Gender: F M*Date of Birth: Ethnicity (specify):Race.
Quick Insights on Some Viral Issues Dr. Haya Al-Tawalah Clinical Virologist.
Warning Signs Y es No Unk Persistent Vomiting…………..... Abdominal pain/Tenderness.. Mucosal Bleeding …………….. Lethargy, restlessness……….… Liver Enlargement.
*Facility ID # : _____________ *HCW ID # : _____________ Social Security # : ___ ___ ___ - ___ ___ - ___ ___ ___ ___ Secondary ID # : _____________ HCW.
Dengue Hemorrhagic Fever: The Sensitivity and Specificity of the WHO Definition for Identification of Severe Cases of Dengue in Thailand, 1994–2005 R2.
The Case of the Mystery Disease.  Public Health Official  Physician  Laboratory Scientist  Field Researcher.
*Facility ID:*Event #: *Patient ID:Social Security #: Secondary ID: Patient Name, Last: First: Middle: *Gender: F M Other *Date of Birth: Ethnicity (specify):Race.
Facility Information: *Facility Name: __________________________________________________________________ *Main Telephone Number: ( ) ______-____________.
Diagnostic Testing for Zika Virus Frederick S. Nolte, PhD, D(ABMM), F(AAM) Professor and Vice-Chair for Laboratory Medicine Department of Pathology and.
Measles Skin rash, fever, running nose, Transmission by inhalation Lab. D Collect throat swab, blood, Blood for.
VIRAL HAEMORRHAGIC FEVERS BY DR UCHE UNIGWE. Lassa fever Yellow fever Marburg/Ebola HF Dengue HF Crimean- Congo HF Hanta virus HF.
DENGUE FEVER Prof. Dr. Muhammad Ali Khan MBBS, DCH, MRCP (UK)
Measles and Rubella Surveillance in the time of Zika: Brazil
Mosquito Borne Diseases
Internal Medicine Workshop Series Laos September /October 2009
Ebola Facts October 14, 2014.
Zika.
MALARIA By Group 8 (WHO Group)
Dr.Humra nasim PGT-Medicine HFH,RWP
Infection Control Q and A APIC Greater NY Chapter 13 May 17, 2017 Beth Nivin BA MPH NYC DOHMH Communicable Disease Program
Epidemiology Clinical features Epidemiological Investigation
Pantila Taweewigyakarn(1) Darin Areechokchai(2)
Most cases occur in older children and adults
Immune System Clinical Case Problem
is caused by the Hepatitis A virus (HAV)
VIRAL HAEMORRHAGIC FEVERS
CLINICAL PROFILE OF DENGUE FEVER
Dengue Fever Information for Interning
Utah Zika investigation, July 2016
Written by : Ali Mohraq Hadadi, Medical Lab Specialist
Zika Virus Disease 2/1/2016.
Yellow fever deepak b. saxena.
Dengue Eva Archer BIO 402.
BY DR. MUDAMA PRECIOUS (M.B.B.S., BENIN)
Ebola Facts October 14, 2014.
Case Definition: HEPATITIS C
Dengue Virus Infections Investigation Guideline
Dr. Keerti Singh Assistant Professor SGRRITS
Ebola Facts October 14, 2014.
Haemophilus Influenzae
Ebola Facts October 14, 2014.
Ebola Facts October 14, 2014.
Hepatitis B Training information for support workers
Influenza Presentation for Health Care Workers
Varicella Vaccine Efficacy Estimates
Hepatitis A Infections Signs and Symptoms
Complementary algorithm for serological testing of specimens with an initial IgM-positive or indeterminate result 5 Collect an adequate serum sample within.
Presentation transcript:

DENGUE CASE INVESTIGATION REPORT CDC Dengue Branch and Puerto Rico Department of Health 1324 Calle Cañada, San Juan, P. R Tel. (787) , Fax (787) Form Approved OMB No CDC A REV. 11/2008 (Front) FOR CDC DENGUE BRANCH USE ONLY Tourniquet test Not done Pos Neg 4.Evidence of capillary leak Pleural or abdominal effusionYes No Unk Lowest hematocrit (%) Highest hematocrit (%) Lowest serum albumin Lowest serum protein 5.Lowest blood pressure (SBP/DBP) __________/__________ Lowest pulse pressure (systolic - diastolic) _________ Name (complete) Relationship with patient: Tel: Fax: Who filled out this form? Physician who referred this case Name of Healthcare Provider: Tel: Fax: Send laboratory results to (mailing address) : Criteria for DENGUE HEMORRHAGIC FEVER (#1-4), SHOCK (#5) and other symptoms Specimen # Days post onset (DPO) Type Date Received S1 _____/_____/_____ S2 _____/_____/_____ Specimen #Days post onset (DPO)Type Date Received S3_____/_____/_____ S4_____/_____/_____ Case number GCODE SAN ID City: Zip code: __ __ __ __ __ - __ __ __ __ Tel: Other Tel: Residence is close to: Work address: Home (Physical) Address Day Month Year Date of first symptom:_______/_______/_______ Date specimen taken: Serum:First sample_______/_______/_______ (Acute = first 5 days of illness – check for virus) Second sample_______/_______/_______ (Convalescent = more than 5 days after onset – check for antibodies) Third sample_______/_______/_______ Fatal cases (tissue type):______________________________/_______/_______ Must have the following information for sample processing Please read and complete ALL sections Hospitalized due to this illness: No Yes → Hospital Name: Name of Patient: If patient is a minor, name of father or primary caregiver: Last NameFirst NameMiddle Name or Initial Fatal: Yes No Unk Mental Status Changes: Yes No Unk Date of Birth:Age:month Sex: M F _______/_______/_______ or Age: years Pregnant Y N UNK WEEKS? Patient’s Demographic Information YesNoUnk 1.Fever (>38ºC) 2.Platelets ≤100,000/mm 3 Platelet count: ______________________________ 3.Any hemorrhagic manifestation Petechiae Purpura/Ecchymosis Vomit with blood Blood in stool Nasal bleeding Bleeding gums Blood in urine Vaginal bleeding Positive urinalysis (over 5 RBC/hpf or positive for blood) Other symptoms Yes No Unk Rapid, weak pulse Pallor or cool skin Headache Eye pain Body pain Lowest white blood cell count (WBC) ________________ Other symptoms YesNoUnk Joint pain Rash Chills Nausea or vomiting Diarrhea Abdominal pain Cough Conjunctivitis Nasal Congestion Sore throat Jaundice Convulsion or coma Anorexia Got Yellow Fever Vaccine Year vaccinated___________________ Additional Patient Data 1.How long have you lived in this city? 2.Country of birth 3.Have you been diagnosed with dengue before? Yes No Unk 4.When diagnosed?_______/_______ Unk Month Year 5.During the 14 days before onset of illness, did you TRAVEL to other cities or countries?Yes, another countryYes, another city No Unk 6.WHERE did you TRAVEL? Day MonthYear Home address here Patient Data Today’s date: _______/_______/_______ Day Month Year

CDC A REV. 11/2008 (Back) DENGUE CASE INVESTIGATION REPORT FOR CDC DENGUE BRANCH USE ONLY Specimen No. S 1 _________________________________ S 2 _________________________________ S 3 _________________________________ SEROLOGY LUMINEX (MIA) S 1 S 2 S 3 Test DateAgTiterTest DateAgTiterTest DateAgTiter IgG ELISA S 1 S 2 S 3 Test DateAgScreenTiterTest DateAgScreenTiterTest DateAgScreenTiter IgM ELISA S 1 S 2 S 3 Neutralization S 1 S 2 S 3 Test DateScreenTiterTest DateScreenTiterTest DateScreenTiter DENV-1 DENV-2 DENV-3 DENV-4 WEST NILE SLE YFV Viral Isolation & PCR S 1 S 2 S 3 Test Date IDIsotechIDtech Test Date IDIsotechIDtech Test Date IDIsotechIDtech This questionnaire is authorized by law (Public Health Service Act 42 USC 241). Although response to the questions asked is voluntary, cooperation of the patient is necessary for the study and control of the disease. Public reporting burden for the collection of information is estimated to average 15 minutes per response. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing the burden to PHS Reports Clearance Officer; Rm. 721-H, Humphrey Bg; 200 Independence Ave., SW; Washington, DC 20201; ATTN: PRA, and to the Office of information and Regulatory Affaire, Office of Management and Budget, Washington, DC. CS Virology Lab Director Signature: ______________________________________ Overall dengue interpretation: _________________________________ Serology Lab Director Signature: ______________________________________ Test DateAgP/NTest DateAgP/NTest DateAgP/N